Last 47 quarters of trend data · Healthcare · Medical - Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -49.92 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 131.41 | — | 92.63 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 19.03 | 11.00 | 10.37 | 11.34 | 8.76 | 11.90 | 13.06 | 19.75 | 18.54 | 15.68 | 13.65 | 11.79 | 11.73 | 10.69 | 8.12 | 7.32 | 8.89 | 7.40 | 10.57 | 7.12 | 7.95 |
| — | -7.6% | -20.6% | -42.6% | -52.7% | -24.1% | -4.3% | +67.5% | +58.0% | +46.7% | +68.2% | +61.1% | +31.9% | +44.5% | -23.2% | +2.8% | +11.9% | -41.2% | -25.1% | -38.5% | -6.9% | |
| P/B Ratio | 14.27 | 11.96 | 9.31 | 9.90 | 6.08 | 7.72 | 7.30 | 10.87 | 10.73 | 9.02 | 10.37 | 8.41 | 7.67 | 7.03 | 4.72 | 3.93 | 4.62 | 3.82 | 4.79 | 3.55 | 3.95 |
| — | +54.9% | +27.6% | -8.9% | -43.3% | -14.4% | -29.7% | +29.2% | +39.9% | +28.3% | +119.9% | +113.9% | +65.9% | +83.9% | -1.5% | +10.8% | +16.9% | -43.1% | -26.4% | -30.1% | +18.1% | |
| P/FCF | — | 168.90 | — | 413.15 | — | 254.69 | — | — | — | — | — | — | — | — | — | — | — | — | 225.74 | — | 75.43 |
| — | -33.7% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 42.02 | — | 33.66 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 86.04 | — | 67.17 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 77.5% | 81.7% | 77.9% | 77.8% | 78.4% | 78.3% | 77.2% | 72.9% | 76.6% | 76.4% | 76.3% | 77.1% | 76.3% | 75.0% | 75.5% | 75.8% | 76.3% | 75.5% | 74.8% | 77.0% | 79.4% |
| — | +4.3% | +0.8% | +6.8% | +2.3% | +2.5% | +1.1% | -5.5% | +0.5% | +1.9% | +1.1% | +1.6% | -0.1% | -0.6% | +1.0% | -1.5% | -3.9% | -2.3% | -1.0% | +5.1% | +9.8% | |
| Operating Margin | -17.1% | -9.3% | -13.2% | -18.9% | -12.3% | -18.3% | -19.4% | -27.2% | -25.5% | -31.3% | -45.6% | -46.9% | -35.9% | -36.2% | -44.6% | -47.4% | -30.3% | -50.6% | 14.5% | -24.4% | 14.8% |
| — | +49.1% | +32.0% | +30.6% | +52.0% | +41.6% | +57.5% | +42.1% | +28.9% | +13.4% | -2.2% | +1.0% | -18.4% | +28.5% | -408.6% | -94.1% | -305.5% | -177.7% | +183.3% | -56.8% | +177.4% | |
| Net Margin | -37.0% | -9.9% | -13.1% | -93.4% | -12.2% | -15.8% | -17.0% | -31.8% | -22.1% | -52.8% | -47.7% | -44.7% | -39.0% | -40.8% | -46.9% | -44.2% | -38.7% | -62.6% | 7.9% | -29.9% | 8.3% |
| — | +37.5% | +22.8% | -193.4% | +45.1% | +70.0% | +64.3% | +28.7% | +43.2% | -29.4% | -1.8% | -1.1% | -0.8% | +34.9% | -689.8% | -47.9% | -564.0% | -179.9% | +132.8% | -105.4% | +134.3% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -26.4% | -2.7% | -3.0% | -18.7% | -2.1% | -2.6% | -2.4% | -4.7% | -3.2% | -9.1% | -9.0% | -7.8% | -6.3% | -6.6% | -6.7% | -5.8% | -5.0% | -7.9% | 0.9% | -3.7% | 1.1% |
| — | -5.6% | -25.8% | -300.7% | +34.1% | +71.6% | +73.5% | +40.2% | +49.0% | -37.7% | -34.2% | -34.2% | -26.9% | +16.2% | -834.6% | -58.5% | -572.3% | -163.6% | +134.6% | -129.7% | +144.2% | |
| ROA | -20.1% | -2.0% | -2.2% | -14.1% | -1.6% | -2.0% | -1.9% | -3.5% | -2.3% | -5.5% | -4.2% | -3.8% | -3.2% | -3.4% | -3.4% | -3.0% | -2.7% | -4.4% | 0.5% | -2.0% | 0.6% |
| — | -0.7% | -18.4% | -299.8% | +29.5% | +63.1% | +55.6% | +6.1% | +27.4% | -60.4% | -24.4% | -24.5% | -18.2% | +22.2% | -786.2% | -51.5% | -557.4% | -158.4% | +130.4% | -87.3% | +137.4% | |
| ROIC | -9.3% | -1.9% | -2.2% | -2.7% | -1.6% | -2.2% | -2.1% | -3.0% | -2.5% | -2.9% | -3.8% | -3.8% | -2.7% | -2.7% | -3.1% | -3.1% | -1.9% | -3.2% | 0.8% | -1.5% | 1.0% |
| — | +13.5% | -1.7% | +9.3% | +36.5% | +23.3% | +43.8% | +21.6% | +8.8% | -6.4% | -23.3% | -23.2% | -41.2% | +14.9% | -465.1% | -102.7% | -300.6% | -154.8% | +180.7% | -52.3% | +178.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.21 | 0.15 | 0.15 | 0.21 | 0.14 | 0.14 | 0.14 | 0.13 | 0.24 | 0.24 | 0.85 | 0.83 | 0.80 | 0.79 | 0.75 | 0.72 | 0.70 | 0.68 | 0.64 | 0.65 | 0.64 |
| — | +9.8% | +11.2% | +57.9% | -42.3% | -41.7% | -83.8% | -83.8% | -70.7% | -70.2% | +12.9% | +15.4% | +15.2% | +16.1% | +17.8% | +10.6% | +9.6% | +6.7% | +4.7% | +60.9% | +57.3% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 20.47 | — | 19.46 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 4.69 | 5.04 | 5.43 | 4.69 | 5.20 | 5.51 | 6.49 | 5.99 | 5.54 | 5.48 | 5.38 | 5.34 | 5.95 | 6.28 | 6.67 | 6.13 | 7.40 | 6.78 | 8.84 | 7.67 | 7.91 |
| — | -8.5% | -16.3% | -21.7% | -6.2% | +0.6% | +20.6% | +12.1% | -6.9% | -12.8% | -19.3% | -12.9% | -19.6% | -7.3% | -24.6% | -20.0% | -6.4% | +382.9% | +525.1% | -18.8% | -18.7% | |
| Quick Ratio | 4.06 | 4.46 | 4.73 | 4.06 | 4.47 | 4.69 | 5.62 | 5.22 | 4.71 | 4.67 | 4.68 | 4.78 | 5.36 | 5.66 | 6.02 | 5.61 | 6.84 | 6.38 | 8.39 | 7.31 | 7.60 |
| — | -5.0% | -15.7% | -22.2% | -5.1% | +0.5% | +19.9% | +9.3% | -12.2% | -17.5% | -22.1% | -14.9% | -21.7% | -11.2% | -28.3% | -23.2% | -10.0% | +371.1% | +513.4% | -19.9% | -18.4% | |
| Interest Coverage | -40.65 | -11.15 | -16.15 | -121.00 | -12.61 | -15.86 | -14.32 | -20.43 | -11.77 | -13.97 | -10.73 | -9.71 | -7.95 | -8.53 | -9.04 | -8.14 | -6.85 | -12.37 | 2.67 | -5.50 | 2.88 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying GKOS stock.
Glaukos Corporation's current P/E is -49.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Glaukos Corporation's current operating margin is -17.1%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Glaukos Corporation's business trajectory between earnings reports.